Several stocks in the health care technology space are moving higher after the market close on Thursday after the U.S. Food and Drug Administration (FDA) announced plans to phase out animal testing requirements.
What Happened: The FDA on Thursday announced plans to replace animal testing in the development of monoclonal antibody therapies and other drugs with human-relevant methods.
The FDA said it will phase out animal testing requirements in favor of AI-based computational models of toxicity and cell lines and organoid toxicity testing. Implementation …Full story available on Benzinga.com
Jared Isaacman confirmed as next head of NASA
...
Read moreDetails